Goldman Sachs
CNMD icon

Goldman Sachs’s CONMED CNMD Stock Holding History

Goldman Sachs’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,000
Closed -$275K – 6259
2021
Q2 		$275K Hold
2,000
– – ﹤0.01% 5569
2021
Q1 		$261K Hold
2,000
– – ﹤0.01% 5498
2020
Q4 		$224K Buy
+2,000
New +$189K ﹤0.01% 5035

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Goldman Sachs's CNMD Position: Q2 2026 in Review

Goldman Sachs reduced its CONMED (CNMD) stake by 8.4% in Q2 2026, selling an estimated $1.43M and leaving 436,830 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2958.

Goldman Sachs first reported a position in CNMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $86.5M in Q4 2021. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Goldman Sachs held 436,830 shares of CONMED worth $14.3M as of Q2 2026.
  • Goldman Sachs sold 39,818 CONMED shares in Q2 2026, an estimated $1.43M.
  • CONMED made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2958 holding.
  • Goldman Sachs first reported a position in CONMED in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's CONMED position peaked at $86.5M in Q4 2021.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.